These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15599100)

  • 1. Combined effects of psychostimulants and morphine on locomotor activity in mice.
    Mori T; Ito S; Narita M; Suzuki T; Sawaguchi T
    J Pharmacol Sci; 2004 Dec; 96(4):450-8. PubMed ID: 15599100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complicated interaction between psychostimulants and morphine in expression of phenotype of behavior in the dopaminergic system of BALB/c mice.
    Ito S; Mori T; Namiki M; Suzuki T; Sawaguchi T
    J Pharmacol Sci; 2007 Dec; 105(4):326-33. PubMed ID: 18057777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
    Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
    Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.
    Kunihara M; Ohyama M; Nakano M
    Jpn J Pharmacol; 1993 Jul; 62(3):223-30. PubMed ID: 8411771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice.
    Nakagawa T; Fujio M; Ozawa T; Minami M; Satoh M
    Behav Brain Res; 2005 Jan; 156(2):233-9. PubMed ID: 15582109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA; Reed B; Kreek MJ
    Neuropharmacology; 2018 Sep; 140():174-183. PubMed ID: 30048644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.
    Brent PJ; Bot G
    Psychopharmacology (Berl); 1992; 107(4):581-90. PubMed ID: 1603903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics.
    Mori T; Iwase Y; Murata A; Iwata N; Suzuki T
    Behav Brain Res; 2016 Jun; 306():64-70. PubMed ID: 26992824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice.
    Ito S; Mori T; Sawaguchi T
    Behav Pharmacol; 2006 Dec; 17(8):691-701. PubMed ID: 17110795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine.
    Kantak KM; Riberdy A; Spealman RD
    Psychopharmacology (Berl); 1999 Dec; 147(3):257-65. PubMed ID: 10639683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
    Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H
    Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of diazepam on six drug-induced locomotor hyperactivities in mice (author's transl)].
    Soubrié P; Simon P; Boissier JR
    Psychopharmacologia; 1975 Dec; 45(2):197-201. PubMed ID: 129788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine.
    Kuribara H; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Feb; 26(1):37-48. PubMed ID: 2069536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-independent psychostimulant activity of a delta-agonist.
    Ito S; Mori T; Sawaguchi T
    Behav Pharmacol; 2008 Mar; 19(2):113-9. PubMed ID: 18332675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines.
    Masukawa Y; Suzuki T; Misawa M
    Psychopharmacology (Berl); 1993; 111(2):139-43. PubMed ID: 7870944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: comparison with methamphetamine and cocaine.
    Yoshizawa K; Narita M; Mori T; Miyatake M; Isotani K; Tomiyasu S; Tsukiyama Y; Suzuki T
    Addict Biol; 2012 Nov; 17(6):949-55. PubMed ID: 21054688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids involvement in the control of CNS excitability.
    Capasso A
    Recent Pat CNS Drug Discov; 2007 Jun; 2(2):155-65. PubMed ID: 18221228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.